Clinical trial
Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By…
NCT00321594 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00321594 |
|---|---|
| Title | Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery |
| Official title | A Phase I/II Study of PXD101 in Patients With Unresectable Hepatocellular Carcinoma With Pharmacokinetic and Pharmacodynamic Evaluation |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer |
| Intervention type | Drug |
| Interventions | belinostat |
| Enrollment | 54 |
| Start date | May 1, 2006 |
| Primary completion | Aug 1, 2010 |
| Completion | Oct 1, 2012 |
| First posted | May 4, 2006 |
| Last update posted | Nov 6, 2017 |
| Countries | Singapore, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: